Share statistics (as at 31 August 2019)

Number of Ordinary Shares in issue (undiluted) 204,660,267
Number of Ordinary Shares subject to options 6,175,000
Maximum number of Ordinary Shares in issue (fully diluted) 214,215,275

The effect of the options, if all were exercised, would be to increase the issued share capital by 3.02% and raise £2,193,650 for the Company.

There are no restrictions on the transfer of Futura Medical plc shares.

Major shareholders (as at 31 August 2019)

Shareholders holding more than 3% of the share capital of Futura were:

Lombard Odier Asset Management (Europe) Limited 13.97%
T Adams 7.06%
RA Lamb 4.68%
WT Lamb Investments Limited 4.49%

Shares not in public hands (as at 31 August 2019)

In terms of the AIM Rules and insofar as it is aware, 16.73% of the Company's AIM securities are not in public hands.

Shares held in treasury (as at 31 August 2019)

In terms of the AIM Rules, there are no shares held in treasury.

Share volumes (as at 31 August 2019)

The daily average number of shares traded since 2014 is:

Daily Average Per Year Since 2014 ('000)
2018 459
2017 309
2016 295
2015 155
2014 154
Daily Average Per Month in 2019 ('000)
January 1422
February 313
March 502
April 1134
May 1448
June 906
July 1202
August 499
September -
October -

Share options (as at 31 August 2019)

The number of ordinary shares subject to options granted under the Share Option Schemes of the Company were:

Grant Exercise period (incl) Exercise
price/share
No of share options granted Cash to Company on exercise
09/12 10/14 - 09/19 61.50p 310,000 £190,650
09/13 10/15 - 09/20 71.50p 620,000 £443,300
09/14 10/16 - 09/21 51.75p 580,000 £300,150
09/15 10/17 - 09/22 30.00p 750,000 £225,000
01/17 10/18 - 09/23 57.50p 960,000 £552,000
09/17 10/19 - 09/24 30.50p 1,140,000 £347,700
11/18 10/20 - 09/25 7.50p 1,390,000 £104,250
01/19 01/20-12/24 7.20p 212,500 £15,300
01/19 09/20-10/25 7.20p 212,500 £15,300
Totals 6,175,000 £193,650

Further details of share options issued can be obtained from the Company's Annual Report 2018 which can be found in the Corporate Documentation.